UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Miotic action of tramadol is determined by CYP2D6 genotype

Physiological research, 2007-01, Vol.56 (1), p.129-136

2007

Volltextzugriff (PDF)

Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity

Drug metabolism and disposition, 2009-08, Vol.37 (8), p.1611

2009

Volltextzugriff (PDF)

Identification of Novel Toxicity-associated Metabolites by Metabolomics and Mass Isotopomer Analysis of Acetaminophen Metabolism in Wild-type and Cyp2e1-null Mice

The Journal of biological chemistry, 2008-02, Vol.283 (8), p.4543-4559

2008

Volltextzugriff (PDF)

Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated β-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6

Toxicology and applied pharmacology, 2006-11, Vol.216 (3), p.387-398

2006

Volltextzugriff (PDF)

Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene

FEBS letters, 1996-08, Vol.392 (1), p.30-34

1996

Volltextzugriff (PDF)

CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response

European journal of clinical pharmacology, 2006-01, Vol.62 (1), p.75-76

2006

Volltextzugriff (PDF)

Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T

European journal of clinical pharmacology, 2007-04, Vol.63 (4), p.419-421

2007

Volltextzugriff (PDF)

Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype

British journal of psychiatry, 1997-01, Vol.170 (1), p.23-26

1997

Volltextzugriff (PDF)

Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity

Chemical research in toxicology, 2009-04, Vol.22 (4), p.699

2009

Volltextzugriff (PDF)

Nomenclature for human CYP2D6 alleles

Pharmacogenetics (London), 1996-06, Vol.6 (3), p.193-201

1996

Volltextzugriff (PDF)

The effect of pregnane X receptor (PXR)‐mediated CYP3A induction on acetaminophen hepatotoxicity

The FASEB journal, 2007, Vol.21 (6), p.A1184-A1184

2007

Volltextzugriff (PDF)

Genetically determined oxidation capacity and the disposition of debrisoquine

British journal of clinical pharmacology, 1983-04, Vol.15 (4), p.443-450

1983

Volltextzugriff (PDF)

A phase I study on the reversal of multidrug resistance (MDR) in vivo : nifedipine plus etoposide

British journal of cancer, 1992-02, Vol.65 (2), p.267-270

1992

Volltextzugriff (PDF)

The N‐oxidation of trimethylamine in a Jordanian population

British journal of clinical pharmacology, 1995-02, Vol.39 (2), p.179-181

1995

Volltextzugriff (PDF)

Genetic aspects of the polymodally distributed sulphoxidation of S‐ carboxymethyl‐L‐cysteine in man

British journal of clinical pharmacology, 1984-10, Vol.18 (4), p.507-521

1984

Volltextzugriff (PDF)

The rationale for case‐control methodology in epidemiological studies of cancer risk (response to Speirs et al., 1990) [see comments]

British journal of clinical pharmacology, 1990-07, Vol.30 (1), p.149-150

1990

Volltextzugriff (PDF)

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology

Pharmacogenetics (London), 1995-08, Vol.5 (4), p.215-223

1995

Volltextzugriff (PDF)

CYP2D6 phenotype : genotype relationships in African-Americans and Caucasians in Los Angeles

Pharmacogenetics (London), 1998-12, Vol.8 (6), p.529-541

1998

Volltextzugriff (PDF)

The influence of food on the pharmacokinetics of ‘biphasic’ nifedipine at steady state in normal subjects

British journal of clinical pharmacology, 1989-11, Vol.28 (5), p.612-615

1989

Volltextzugriff (PDF)

The metabolism of [14C]‐debrisoquine in man

British journal of clinical pharmacology, 1979-03, Vol.7 (3), p.257-266

1979

Volltextzugriff (PDF)

Polymorphic hydroxylation of debrisoquine in Nigerians [proceedings]

British journal of clinical pharmacology, 1980-01, Vol.9 (1), p.112P-113P

1980

Volltextzugriff (PDF)

Inter‐ethnic and inter‐phenotype differences among Ghanaians and Caucasians in the metabolic hydroxylation of phenytoin [proceedings]

British journal of clinical pharmacology, 1980-03, Vol.9 (3), p.282P-283P

1980

Volltextzugriff (PDF)

The influence of changes in dietary fat on the clearance of antipyrine and 4‐hydroxylation of debrisoquine

British journal of clinical pharmacology, 1980-03, Vol.9 (3), p.283P-283P

1980

Volltextzugriff (PDF)

4‐Hydroxylation of debrisoquine in psoriasis [proceedings]

British journal of clinical pharmacology, 1980-01, Vol.9 (1), p.113P-114P

1980

Volltextzugriff (PDF)

Identification of Noninvasive Biomarkers for Alcohol-Induced Liver Disease Using Urinary Metabolomics and the Ppara-null Mouse

Journal of proteome research, 2010-08, Vol.9 (8), p.4176-4188

2010

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Miotic action of tramadol is determined by CYP2D6 genotype

Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity

Identification of Novel Toxicity-associated Metabolites by Metabolomics and Mass Isotopomer Analysis of Acetaminophen Metabolism in Wild-type and Cyp2e1-null Mice

Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated β-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6

Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene

CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response

Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T

Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype

Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity

Nomenclature for human CYP2D6 alleles

The effect of pregnane X receptor (PXR)‐mediated CYP3A induction on acetaminophen hepatotoxicity

Genetically determined oxidation capacity and the disposition of debrisoquine

A phase I study on the reversal of multidrug resistance (MDR) in vivo : nifedipine plus etoposide

The N‐oxidation of trimethylamine in a Jordanian population

Genetic aspects of the polymodally distributed sulphoxidation of S‐ carboxymethyl‐L‐cysteine in man

The rationale for case‐control methodology in epidemiological studies of cancer risk (response to Speirs et al., 1990) [see comments]

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology

CYP2D6 phenotype : genotype relationships in African-Americans and Caucasians in Los Angeles

The influence of food on the pharmacokinetics of ‘biphasic’ nifedipine at steady state in normal subjects

The metabolism of [14C]‐debrisoquine in man

Polymorphic hydroxylation of debrisoquine in Nigerians [proceedings]

Inter‐ethnic and inter‐phenotype differences among Ghanaians and Caucasians in the metabolic hydroxylation of phenytoin [proceedings]

The influence of changes in dietary fat on the clearance of antipyrine and 4‐hydroxylation of debrisoquine

4‐Hydroxylation of debrisoquine in psoriasis [proceedings]

Identification of Noninvasive Biomarkers for Alcohol-Induced Liver Disease Using Urinary Metabolomics and the Ppara-null Mouse

Suchergebnisse filtern